cancer

Placental Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study

According to the peer-reviewed article in the journal Scientific Reports, placenta-derived cells called PLX cells, exhibit a strong inhibitory effect on various lines of breast, colorectal, kidney, liver, lung, muscle and skin cancers. The research was conducted over more than two years by Pluristem Therapeutics, Inc., a Haifa-based biotechnology company. The article titled “Human Placental-Derived Adherent […]

Cardiology

Newly Published Data Highlights the Potential of Placenta-based Cell Therapy in Protecting the Heart Affected by Diabetes

Results from a peer-reviewed study in the peer-reviewed journal STEM CELLS Translational Medicine. showed that treating the heart with placenta-based cell therapy called PLX cells, led to improved diastolic function by significantly decreasing cardiomyocyte stiffness, endothelial inflammation, and improving vascularization in preclinical studies. The study’s authors believe the study holds the promise that PLX cells […]